Park, Neung Hwa

Publishing since 1991 (Senior)

Has published 136 publications in 20 years

Number of publications published per year by Park, Neung Hwa. (Source : PubMed)

Distribution of publications types for Park, Neung Hwa. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Song BC, Cui XJ, Shin JW, Park NH, Cho YK, Song HJ, Hyun S, Jeong SU, Choi EK, Kim HU. Response to Adefovir Depends on Mutation Patterns in Precore Region, Basal Core Promoter and Reverse Transcriptase, and On-Treatment Responses in Lamivudine-Resistant Chronic Hepatitis B Patients.  Intervirology  2010;53;4  
•  Jung SW, Jeong ID, Bang SJ, Shin JW, Park NH, Kim do H. Successful outcomes of endoscopic resection for gastric adenomas and early cancers located on the pyloric ring (with video).  Gastrointest. Endosc.  2010;71;3  
•  Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.  Gastroenterology  2010;138;3  
•  Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period.  Intervirology  2010;53;1  
•  Lee JS, Park ET, Kang SS, Gu ES, Kim JS, Jang DS, Lee KS, Lee JS, Park NH, Bae CH, Baik SK, Yu BJ, Lee SH, Lee EJ, Park SI, Bae M, Shin JW, Choi JH, Gu C, Moon SK, Chun GJ, Kim JH, Kim HS, Choi SK. Clevudine demonstrates potent antiviral activity in naïve chronic hepatitis B patients.  Intervirology  2010;53;2  
•  Kim K, Kim MJ, Chung HH, Choi SC, Ryu SY, Kim JW, Park NH, Song YS, Kang SB. Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer.  Med. Hypotheses  2009;73;6  
•  Kim HS, Kim TJ, Chung HH, Kim JW, Kim BG, Park NH, Song YS, Bae DS, Kang SB. In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study.  J. Cancer Res. Clin. Oncol.  2009;135;11  
•  No JH, Jeon YT, Park IA, Kang D, Kim JW, Park NH, Kang SB, Song YS. Expression of mTOR protein and its clinical significance in endometrial cancer.  Med. Sci. Monit.  2009;15;10  
•  Kim K, Chung HH, Kim JW, Park NH, Song YS, Kang SB. Clinical impact of under-diagnosis by frozen section examination is minimal in borderline ovarian tumors.  Eur J Surg Oncol  2009;35;9  
•  Lee YK, Choi E, Kim MA, Park PG, Park NH, Lee H. BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.  Br. J. Cancer  2009;101;3  

[ See timeline ] [ See all publications ]